EMEA-002708-PIP02-21

Table of contents

Key facts

Active substance
Verdiperstat
Therapeutic area
Neurology
Decision number
P/0523/2021
PIP number
EMEA-002708-PIP02-21
Pharmaceutical form(s)
Modified-release tablet
Condition(s) / indication(s)
Treatment of amyotrophic lateral sclerosis
Route(s) of administration
Oral use
Contact for public enquiries
Biohaven Pharmaceutical Ireland DAC

Email: medinfo@biohavenpharma.com
Tel. +1 2034040410

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating